{
    "Trade/Device Name(s)": [
        "EUROIMMUN Anti-SLA/LP ELISA (IgG)",
        "Anti-SLA/LP ELISA (IgG)"
    ],
    "Submitter Information": "EUROIMMUN US INC.",
    "510(k) Number": "K112221",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021482"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NIY"
    ],
    "Summary Letter Date": "September 5, 2012",
    "Summary Letter Received Date": "September 7, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Anti-SLA/LP autoantibodies",
        "IgG autoantibodies against soluble liver antigen/liver-pancreas antigen (SLA/LP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Microwell plate reader (capable of measuring OD at 450nm and at 620nm)"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "ELISA"
    ],
    "Methodologies": [
        "Qualitative enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for EUROIMMUN Anti-SLA/LP ELISA (IgG), a qualitative ELISA for detection of IgG anti-SLA/LP autoantibodies as an aid in diagnosing autoimmune hepatitis type 1.",
    "Indications for Use Summary": "For qualitative detection of IgG class autoantibodies against SLA/LP in human serum and plasma, used as an aid in the diagnosis of autoimmune hepatitis type 1, in conjunction with other laboratory and clinical findings.",
    "fda_folder": "Immunology"
}